Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors

Hiroyuki Nakai, Theresa A. Storm, Mark A. Kay

Research output: Contribution to journalArticle

155 Citations (Scopus)

Abstract

A major shortcoming to the use of adeno-associated virus (rAAV) vectors is their limited packaging size. To overcome this hurdle, we split an expression cassette and cloned it into two separate vectors. The vectors contained either a nuclear localizing Escherichia coli lacZ transgene (nlslacZ) with a splice acceptor, or the human elongation factor 1α (EF1α) gene enhancer/promoter(s) (EF1αEP) with a splice donor. We co-injected a promoter-less nlslacZ vector with a vector containing either a single EF1αEP or a double copy of the EF1αEP in a head-to-head orientation, into the portal vein of mice. Gene expression, measured by both transduction efficiency and quantitation of the recombinant protein, was as much as 60-70% of that obtained from mice that received a single vector containing a complete EF1αEP/nlslacZ expression cassette. This two-vector approach may allow development of gene therapy strategies that will carry exogenous DNA sequences with large therapeutic cDNAs and/or regulatory elements.

Original languageEnglish (US)
Pages (from-to)527-532
Number of pages6
JournalNature Biotechnology
Volume18
Issue number5
DOIs
StatePublished - May 2000
Externally publishedYes

Fingerprint

Joining
Peptide Elongation Factor 1
Dependovirus
Product Packaging
Portal Vein
Transgenes
Recombinant Proteins
Genetic Therapy
Complementary DNA
Escherichia coli
Gene Expression
Genes
Gene therapy
Recombinant proteins
DNA sequences
Viruses
Gene expression
Therapeutics
Elongation
Packaging

Keywords

  • Adeno-associated virus vector
  • Concatemer
  • Gene therapy
  • Hepatocytes
  • Intermolecular recombination

ASJC Scopus subject areas

  • Microbiology

Cite this

Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. / Nakai, Hiroyuki; Storm, Theresa A.; Kay, Mark A.

In: Nature Biotechnology, Vol. 18, No. 5, 05.2000, p. 527-532.

Research output: Contribution to journalArticle

@article{be459c0aacd84754bcda3be19b73ea6c,
title = "Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors",
abstract = "A major shortcoming to the use of adeno-associated virus (rAAV) vectors is their limited packaging size. To overcome this hurdle, we split an expression cassette and cloned it into two separate vectors. The vectors contained either a nuclear localizing Escherichia coli lacZ transgene (nlslacZ) with a splice acceptor, or the human elongation factor 1α (EF1α) gene enhancer/promoter(s) (EF1αEP) with a splice donor. We co-injected a promoter-less nlslacZ vector with a vector containing either a single EF1αEP or a double copy of the EF1αEP in a head-to-head orientation, into the portal vein of mice. Gene expression, measured by both transduction efficiency and quantitation of the recombinant protein, was as much as 60-70{\%} of that obtained from mice that received a single vector containing a complete EF1αEP/nlslacZ expression cassette. This two-vector approach may allow development of gene therapy strategies that will carry exogenous DNA sequences with large therapeutic cDNAs and/or regulatory elements.",
keywords = "Adeno-associated virus vector, Concatemer, Gene therapy, Hepatocytes, Intermolecular recombination",
author = "Hiroyuki Nakai and Storm, {Theresa A.} and Kay, {Mark A.}",
year = "2000",
month = "5",
doi = "10.1038/75390",
language = "English (US)",
volume = "18",
pages = "527--532",
journal = "Biotechnology",
issn = "1087-0156",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors

AU - Nakai, Hiroyuki

AU - Storm, Theresa A.

AU - Kay, Mark A.

PY - 2000/5

Y1 - 2000/5

N2 - A major shortcoming to the use of adeno-associated virus (rAAV) vectors is their limited packaging size. To overcome this hurdle, we split an expression cassette and cloned it into two separate vectors. The vectors contained either a nuclear localizing Escherichia coli lacZ transgene (nlslacZ) with a splice acceptor, or the human elongation factor 1α (EF1α) gene enhancer/promoter(s) (EF1αEP) with a splice donor. We co-injected a promoter-less nlslacZ vector with a vector containing either a single EF1αEP or a double copy of the EF1αEP in a head-to-head orientation, into the portal vein of mice. Gene expression, measured by both transduction efficiency and quantitation of the recombinant protein, was as much as 60-70% of that obtained from mice that received a single vector containing a complete EF1αEP/nlslacZ expression cassette. This two-vector approach may allow development of gene therapy strategies that will carry exogenous DNA sequences with large therapeutic cDNAs and/or regulatory elements.

AB - A major shortcoming to the use of adeno-associated virus (rAAV) vectors is their limited packaging size. To overcome this hurdle, we split an expression cassette and cloned it into two separate vectors. The vectors contained either a nuclear localizing Escherichia coli lacZ transgene (nlslacZ) with a splice acceptor, or the human elongation factor 1α (EF1α) gene enhancer/promoter(s) (EF1αEP) with a splice donor. We co-injected a promoter-less nlslacZ vector with a vector containing either a single EF1αEP or a double copy of the EF1αEP in a head-to-head orientation, into the portal vein of mice. Gene expression, measured by both transduction efficiency and quantitation of the recombinant protein, was as much as 60-70% of that obtained from mice that received a single vector containing a complete EF1αEP/nlslacZ expression cassette. This two-vector approach may allow development of gene therapy strategies that will carry exogenous DNA sequences with large therapeutic cDNAs and/or regulatory elements.

KW - Adeno-associated virus vector

KW - Concatemer

KW - Gene therapy

KW - Hepatocytes

KW - Intermolecular recombination

UR - http://www.scopus.com/inward/record.url?scp=0034033447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034033447&partnerID=8YFLogxK

U2 - 10.1038/75390

DO - 10.1038/75390

M3 - Article

C2 - 10802620

AN - SCOPUS:0034033447

VL - 18

SP - 527

EP - 532

JO - Biotechnology

JF - Biotechnology

SN - 1087-0156

IS - 5

ER -